bluebird bio (BLUE) Reports Q1 Loss of $3.64/sh

bluebird bio (NASDAQ: BLUE) reported Q1 EPS of ($3.64), versus ($2.99) reported last year. Revenue for the quarter came in at $21.9 million, versus $12.5 million reported last year.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Jefferies Starts Oversea-Chinese Banking Corp Ltd (OCBC:SP) (OVCHF) at Hold
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold